This inventor holds 2 USPTO granted patents. Top assignee: Rensselaer Polytechnic Institute. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Edmund Francis Palermo: Innovator in Poly(Pro-Drug) Materials
Introduction
Edmund Francis Palermo is a notable inventor based in Delmar, NY (US). He has made significant contributions to the field of biomedical materials, particularly through his innovative work on poly(pro-drug) materials designed for extended drug release.
Latest Patents
Palermo holds a patent for the "Synthesis and processing of poly(pro-drug) materials for extended drug release and uses thereof." This patent describes a unique poly(pro-drug) material that incorporates alternating therapeutic compounds and biodegradable hydrocarbyl groups. These components are separated by cleavable linker compounds, allowing for the controlled release of therapeutic agents such as estrogen, curcumin, and fingolimod. The materials are designed to degrade in aqueous media at physiological temperature and pH, releasing the therapeutic compounds over extended periods, with a zero-order release profile. This innovative approach enables prolonged implantation within patients, making these materials suitable for various biomedical applications, including veterinary medicine, cancer treatments, birth control, and hormone replacement therapy. He has 1 patent to his name.
Career Highlights
Palermo is affiliated with Rensselaer Polytechnic Institute, where he continues to advance research in the field of drug delivery systems. His work has garnered attention for its potential to revolutionize how therapeutic compounds are administered and released in the body.
Collaborations
Some of his notable coworkers include Anthony Richard D'Amato and Ryan James Gilbert, who have contributed to his research endeavors.
Conclusion
Edmund Francis Palermo's innovative work in the development of poly(pro-drug) materials showcases his commitment to advancing biomedical applications. His contributions have the potential to significantly impact the field of drug delivery and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
